PowerShares Dynamic Biotechnology & Genome Portfolio ETF (PBE)
Description
The investment seeks to track the performance of the Dynamic Biotechnology & Genome Intellidex Index. The PBE ETF contains 30 constituents. It is focused on growth holdings in the North America region.
Price $59.39 as of 2022-10-20Cost/Risk/Yield
| Dividend yield | |
| Expense ratio | 0.59% |
| Average spread | 0.253% |
| 1Y roundtrip cost | 0.843% |
Historic prices
Total Returns (including dividends)
Monthly returns heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | -14.7% | -0.8% | 2.9% | -9.3% | 1.3% | 1.4% | 5.7% | -0.9% | -2.5% | 0.8% | -16.2% | ||
| 2021 | 7.9% | -2.0% | -0.5% | 2.2% | -2.9% | 5.6% | -2.5% | 4.1% | -4.7% | 0.3% | -6.1% | 1.0% | 2.5% |
| 2020 | -3.3% | -7.3% | -7.2% | 14.5% | 9.0% | 0.4% | 1.3% | -0.6% | -3.5% | -0.1% | 13.0% | 9.8% | 26.1% |
| 2019 | 11.6% | 4.3% | 0.7% | -5.4% | -7.2% | 10.6% | -1.1% | -5.5% | -5.3% | 7.7% | 8.4% | 0.9% | 19.7% |
| 2018 | 10.5% | -1.8% | -3.8% | -2.3% | 7.0% | 6.3% | 5.0% | 4.5% | -1.0% | -13.8% | 3.4% | -11.2% | 2.9% |
| 2017 | 5.0% | 7.1% | -2.9% | 1.9% | -3.0% | 9.8% | 2.0% | 4.7% | 2.4% | -6.6% | -1.0% | 2.2% | 21.4% |
| 2016 | -23.7% | -4.3% | 3.9% | 2.7% | 3.5% | -9.1% | 11.4% | -2.5% | 4.5% | -10.9% | 9.0% | -4.5% | -20.1% |
| 2015 | 5.5% | 3.5% | 0.6% | -4.0% | 9.2% | 1.1% | 1.9% | -9.9% | -14.4% | 9.4% | 1.9% | -0.3% | 4.5% |
| 2014 | 13.3% | 7.6% | -7.8% | -4.7% | -0.8% | 11.6% | -1.6% | 11.1% | -3.2% | 7.9% | 1.7% | -1.1% | 34.1% |
| 2013 | 8.6% | -0.3% | 6.1% | 7.9% | 5.4% | -3.2% | 13.2% | 0.7% | 6.5% | 0.3% | 8.0% | -2.5% | 50.7% |
| 2012 | 9.1% | 1.4% | 2.2% | -2.0% | -3.9% | 8.6% | -1.4% | 1.5% | 4.0% | -7.8% | 4.7% | -2.0% | 14.4% |
| 2011 | -3.1% | -0.8% | 3.5% | 6.4% | 0.3% | -3.6% | -6.0% | -6.3% | -7.3% | 11.0% | -3.9% | 2.7% | -7.0% |
| 26.8% | 6.5% | -2.4% | 8.0% | 17.9% | 39.5% | 27.8% | 0.9% | -24.4% | -1.9% | 39.3% | -5.0% |
Historical Dividends
Monthly dividend heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | 0.03 | 0.03 | |||||||||||
| 2018 | 0.00 | 0.00 | |||||||||||
| 2017 | 0.06 | 0.21 | 0.27 | ||||||||||
| 2016 | 0.03 | 0.12 | 0.15 | ||||||||||
| 2015 | 0.12 | 0.14 | 0.31 | 0.57 | |||||||||
| 2014 | 0.23 | 0.04 | 0.28 | ||||||||||
| 0.00 | 0.00 | 0.09 | 0.00 | 0.00 | 0.57 | 0.00 | 0.00 | 0.21 | 0.00 | 0.00 | 0.43 |
Sectors and Top Holdings
| Security | % Assets |
|---|---|
| Repligen Corporation | 5.65% |
| Catalent Inc | 5.52% |
| Bio-Techne Corporation | 5.34% |
| Amgen Inc. | 4.69% |
| Incyte Corporation | 4.60% |
| Gilead Sciences, Inc. | 4.55% |
| Illumina, Inc. | 4.36% |
| Biogen Inc. | 3.90% |
| Dynavax Technologies Corporation | 3.72% |
| Avid Bioservices, Inc. | 3.68% |
| Xencor, Inc. | 3.49% |
| Blueprint Medicines Corp. | 3.25% |
| Neurocrine Biosciences, Inc. | 3.13% |
| Exelixis, Inc. | 3.13% |
| Arrowhead Pharmaceuticals, Inc. | 3.08% |
| Top 15 Weights | 62.09% |
Compare with similar ETFs
| PBE | FXH | GXTG | IBB | IXJ | JSML | |
|---|---|---|---|---|---|---|
| Product name | PowerShares Dynamic Biotechnology & Genome Portfolio ETF | First Trust Health Care AlphaDEX Fund | Global X Thematic Growth ETF | iShares Nasdaq Biotechnology ETF | iShares Global Healthcare ETF | Janus Small Cap Growth Alpha ETF |
| Issuer | Invesco | First Trust | Global X | iShares | iShares | Janus Henderson |
| Price | $59.39 | $98.3862 | $25.06 | $117.58 | $76.7 | $44.23 |
| Expense Ratio | 0.59% |  0.61% |  0.5% | 0.45% | 0.43% | 0.3% |
| Average Spread | 0.253% | 0.091% | 0.758% | 0.017% | 0.117% | 0.384% |
| AUM | $226,683,000 | $1,282,640,000 | $54,720,400 | $7,490,990,000 | $3,099,990,000 | $97,905,800 |
| Shares | 3,816,854 | 13,036,782 | 2,183,575 | 63,709,707 | 40,417,143 | 2,213,561 |
| Average Daily Volume | 8,743 | 47,586 | 18,016 | 1,968,141 | 205,363 | 13,709 |
| Home page | Visit external site | Visit external site | Visit external site | Visit external site | Visit external site | Visit external site |
| Inception Date | 2005-06-23 | 2007-05-08 | 2019-10-25 | 2001-02-05 | 2001-11-13 | 2016-02-25 |
| Index Tracked | Dynamic Biotechnology & Genome Intellidex Index | StrataQuant Health Care Index | Solactive Thematic Growth Index | ICE Biotechnology Index | S&P Global 1200 Healthcare Sector Index | Janus Small Cap Growth Alpha Index |
| Category | Health & Biotech Equities | Health & Biotech Equities | Global Equities | Health & Biotech Equities | Health & Biotech Equities | Small Cap Growth Equities |
| Asset Class | Equity | Equity | Equity | Equity | Equity | Equity |
| Asset Class Size | Large/Mid/Small Caps | Large/Mid Caps | Large/Mid Caps | Large/Mid Caps | Large Caps | Mid/Small Caps |
| Value or Growth | Growth | Growth | Blend | Growth | Blend | Growth |
| Region | North America | North America | North America | North America | North America | North America |
| Countries | U.S. | U.S. | Broad | U.S. | Broad | U.S. |
| Annual Dividend Rate | $0 | $0.101 | $0.625 | $0.349 | $1.033 | $0.201 |
| Annual Dividend Yield | 0.000% | 0.001% | 0.025% | 0.003% | 0.013% | 0.005% |
| Number of Holdings | 30 | 88 | 307 | 267 | 115 | 204 |
| YTD Return | -16.60% | -20.68% | -43.57% | -22.76% | -14.53% | -31.80% |
| Beta | 1.22 | 0.93 | 1.02 | 1.25 | 0.87 | 1.23 |
| Upside Beta | 0.12 | 0.07 | 0.47 | 0.31 | 0.25 | 0.79 |
| Downside Beta | 0.09 | -0.09 | -0.50 | 0.31 | 0.17 | 0.00 |
| Volatility 1Y | 30.04% | 20.98% | 35.33% | 28.90% | 17.57% | 31.20% |
| Sharpe Ratio 3Y | 0.31 | 0.65 | 0.00 | 0.20 | 0.69 | 0.01 |
| Treynor Ratio 3Y | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 |